ZLAB — ZAI LAB LTD

Ownership history in &PARTNERS  ·  2 quarters on record

This page tracks every 13F SEC filing in which &PARTNERS reported a position in ZAI LAB LTD (ZLAB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 7,100 +631 +9.8% 0.00% $240K $33.89
2025 Q2 INITIATED 6,469 — — 0.00% $226K $34.97
% of Fund (quarterly)    ZLAB price (monthly, adj. close)

Other funds also holding ZLAB

As of 2025 Q4 — sorted by position size

B Group, Inc. 5.21% XY Capital Ltd 3Y 2.25% SUPERSTRING CAPITAL MANAGEMENT LP 1.86% ADAR1 Capital Management, LLC 1.59% RTW INVESTMENTS, LP 3Y 7Y 1.23% Frazier Life Sciences Management, L.P. 3Y 0.9% Rock Springs Capital Management LP 3Y 7Y 0.73% DCF Advisers, LLC 3Y 0.46% Privium Fund Management B.V. 3Y 0.43% NAN FUNG TRINITY (HK) Ltd 3Y 0.38%
← Back to &PARTNERS Holdings